Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $23,059.96 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 7,487 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total value of $23,059.96. Following the completion of the sale, the chief financial officer now directly owns 97,849 shares of the company’s stock, valued at $301,374.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cardlytics Stock Performance

NASDAQ:CDLX opened at $3.29 on Friday. Cardlytics, Inc. has a 1-year low of $2.89 and a 1-year high of $20.52. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77. The business has a 50 day moving average of $4.24 and a 200 day moving average of $8.41. The company has a market capitalization of $160.50 million, a price-to-earnings ratio of -0.74 and a beta of 1.67.

Cardlytics (NASDAQ:CDLXGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12. The firm had revenue of $69.64 million during the quarter, compared to analyst estimates of $75.39 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The business’s quarterly revenue was down 9.2% on a year-over-year basis. During the same period in the previous year, the business posted ($0.57) EPS. On average, sell-side analysts predict that Cardlytics, Inc. will post -1.72 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in CDLX. Renaissance Technologies LLC increased its stake in shares of Cardlytics by 711.9% in the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock worth $2,882,000 after buying an additional 307,800 shares during the period. Kent Lake Capital LLC purchased a new stake in shares of Cardlytics in the 1st quarter worth about $3,622,000. Perbak Capital Partners LLP purchased a new stake in shares of Cardlytics in the 1st quarter worth about $2,348,000. General Equity Holdings LP grew its position in shares of Cardlytics by 31.0% in the 4th quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after buying an additional 147,843 shares during the period. Finally, Blackstone Inc. purchased a new stake in shares of Cardlytics in the 1st quarter worth about $2,029,000. 68.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CDLX shares. Northland Capmk downgraded Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Craig Hallum cut Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Needham & Company LLC cut Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Lake Street Capital lowered Cardlytics from a “buy” rating to a “hold” rating and reduced their target price for the company from $18.00 to $5.00 in a report on Thursday, August 8th. Finally, Northland Securities cut shares of Cardlytics from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $7.00 to $5.00 in a report on Friday, August 16th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.50.

Read Our Latest Stock Analysis on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.